Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | TEVA | BBIO | RDY | SUPN |
| Company | Cymabay Therapeutics | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 32.49 | 31.26 | 75.85 | 13.40 | 51.62 |
| High | 32.50 | 31.39 | 75.85 | 13.60 | 51.71 |
| Low | 32.48 | 30.58 | 74.26 | 13.31 | 50.00 |
| Latest | 32.48 | 30.82 | 74.59 | 13.31 | 50.68 |
| Change | +0.01 | -0.14 | -0.93 | +0.05 | -0.82 |
| % Change | +0.03% | -0.45% | -1.23% | +0.38% | -1.59% |
| Volume | 8,356,200 | 4,276,600 | 1,075,900 | 1,622,400 | 445,300 |
| 20-Day Average Volume | 3,390,805 | 6,189,060 | 1,562,575 | 2,444,320 | 604,420 |
| Previous Close | 32.47 | 30.96 | 75.52 | 13.26 | 51.50 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 29.60 | 71.59 | 13.62 | 50.20 |
| 20-Day Raw Stochastic | 94.12% | 83.53% | 80.97% | 32.00% | 65.70% |
| 20-Day Relative Strength | 78.00 | 50.69 | 55.02 | 42.96 | 49.10 |
| Weighted Alpha | +247.60 | +115.26 | +105.63 | -3.58 | +52.12 |
| Today's Opinion | 100% Buy | 40% Buy | 72% Buy | 88% Sell | 56% Buy |
| Previous Opinion | 100% Buy | 40% Buy | 72% Buy | 88% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +2.46% since 04/02/26 | +1.97% since 04/02/26 | -0.08% since 04/02/26 | +0.40% since 04/02/26 |
| Low | 32.44 on 03/15/24 | 27.93 on 04/06/26 | 70.52 on 04/07/26 | 12.83 on 04/07/26 | 49.56 on 04/07/26 |
| High | 32.50 on 03/21/24 | 31.39 on 04/10/26 | 76.24 on 04/09/26 | 13.60 on 04/10/26 | 52.37 on 04/08/26 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -2.22% since 03/10/26 | +0.36% since 03/10/26 | -8.27% since 03/10/26 | -5.57% since 03/10/26 |
| Low | 32.15 on 02/22/24 | 27.93 on 04/06/26 | 67.57 on 03/24/26 | 12.83 on 04/07/26 | 46.83 on 03/20/26 |
| High | 32.50 on 03/21/24 | 31.43 on 03/11/26 | 76.24 on 04/09/26 | 14.55 on 03/11/26 | 53.41 on 03/11/26 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -3.72% since 01/09/26 | -3.44% since 01/09/26 | -0.67% since 01/09/26 | -0.84% since 01/09/26 |
| Low | 22.11 on 01/26/24 | 27.93 on 04/06/26 | 62.77 on 03/03/26 | 12.81 on 01/20/26 | 46.83 on 03/20/26 |
| High | 32.50 on 03/21/24 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.80 on 02/25/26 | 59.68 on 02/25/26 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +53.87% since 10/10/25 | +34.42% since 10/10/25 | -7.18% since 10/10/25 | +3.43% since 10/10/25 |
| Low | 12.32 on 10/13/23 | 18.83 on 10/22/25 | 52.75 on 10/23/25 | 12.81 on 01/20/26 | 43.11 on 11/05/25 |
| High | 32.50 on 03/21/24 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.95 on 10/22/25 | 59.68 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 35,437,236 | 14,460,241 | 11,109,111 | 2,918,256 |
| Shares Outstanding, K | 114,724 | 1,149,813 | 193,863 | 834,644 | 57,582 |
| Annual Sales | 31,070,000 | 17,258,000,000 | 502,080,000 | 3,811,000,000 | 718,950,000 |
| Annual Net Income | -105,370,000 | 1,411,000,000 | -724,930,000 | 663,000,000 | -38,550,000 |
| Last Quarter Sales | 60,000 | 4,711,000,000 | 154,180,000 | 977,400,000 | 211,570,000 |
| Last Quarter Net Income | -41,900,000 | 481,000,000 | -192,860,000 | 135,500,000 | -4,110,000 |
| 60-Month Beta | 0.32 | 0.76 | 1.09 | 0.35 | 0.73 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.96 on 01/28/26 | -1.00 on 02/24/26 | 0.16 on 01/21/26 | 0.92 on 02/24/26 |
| Latest Earnings Date | 05/20/24 | 04/29/26 | 05/05/26 | 05/08/26 | 05/05/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.02 | 0.00 | 17.22 | 22.69 |